Glimestar-PM2 Tablet ER
By Glimestar-PM
Rx
10 Tablet ER in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
February, 2026

liver
Glimestar-PM2 Tablet ER should be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of Glimestar-PM2 Tablet ER in such cases, therefore, it is important to seek advice from your doctor before starting or continuing with the medication. It is advised not to use Glimestar-PM2 Tablet ER in patients with severe liver disease. Always consult your healthcare provider for proper guidance when considering the use of this medication.

kidney
Glimestar-PM2 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment may be needed, and it is not recommended for severe kidney disease. Regular monitoring of kidney function is advised during the treatment. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Glimestar-PM2 Tablet ER.

driving
When using Glimestar-PM2 Tablet ER, avoid driving if you experience symptoms of low or high blood sugar. These symptoms can affect your focus and reaction time while driving.

pregnancy
Glimestar-PM2 Tablet ER may not be safe during pregnancy. Animal studies indicate potential harm to the baby. Your doctor will assess benefits versus risks before prescribing. Kindly consult your doctor.

breastfeeding
Glimestar-PM2 Tablet ER is likely unsafe while breastfeeding. Limited data indicate potential harm to the baby through breastmilk exposure.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹125
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024